Sherry L. Ralston
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 4
- Pharmacology top 10%
-
- DNA and Nucleic Acid Chemistry 3
- DNA Repair Mechanisms 2
- Glycosylation and Glycoproteins Research 1
- RNA modifications and cancer 1
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Innovative Microfluidic and Catalytic Techniques Innovation 2
- 3D Printing in Biomedical Research 2
- Co-authors
- William M. BairdAndreas LuchKarl L. PlattAlbrecht SeidelGary D. StonerClifford B. PereiraGeorge BaileyBruce C. Casto
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Sherry L. Ralston
14 papers receiving 518 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 173
- Pharmacology 76
- Toxicology 18
- Health, Toxicology and Mutagenesis 71
- Oncology 127
Countries citing papers authored by Sherry L. Ralston
This map shows the geographic impact of Sherry L. Ralston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry L. Ralston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry L. Ralston more than expected).
Fields of papers citing papers by Sherry L. Ralston
This network shows the impact of papers produced by Sherry L. Ralston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry L. Ralston. The network helps show where Sherry L. Ralston may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sherry L. Ralston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 8 | |
| 3 | 2020 | 77 | |
| 4 | 2018 | 35 | |
| 5 | 2018 | 4 | |
| 6 | 2015 | 20 | |
| 7 | 2007 | 62 | |
| 8 | 2002 | 63 | |
| 9 | 1998 | 23 | |
| 10 | 1997 | 43 | |
| 11 | 1996 | 5 | |
| 12 | 1995 | 110 | |
| 13 | 1994 | 20 | |
| 14 | The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures. | 1994 | 62 |
About Sherry L. Ralston
Sherry L. Ralston is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Statistics and Probability, having authored 14 papers that have together received 533 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), DNA Repair Mechanisms (2 papers), 3D Printing in Biomedical Research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (173 citations), Pharmacology (76 citations) and Toxicology (18 citations). Sherry L. Ralston has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include William M. Baird, Andreas Luch, Karl L. Platt, Albrecht Seidel, Gary D. Stoner, Clifford B. Pereira, George Bailey, Bruce C. Casto, Bill D. Roebuck and A. Seidel. Their work appears in journals such as Cancer Research, Lab on a Chip and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.